Novel peptides functionally targeting in vivo human lung cancer discovered by in vivo peptide displayed phage screening
暂无分享,去创建一个
E. Choi | J. Hwang | Jaesook Park | Inki Kim | S. Park | S. Song | H. Chung | Seong-Yun Jeong | Jinhyang Choi | E. Ju | Seol Hwa Shin | H. Park | E. Ko | Kyoung Jin Lee | J. Park | N. Suh | Jae Hee Lee | S. Shin
[1] Jie Zhao,et al. Involvement of RECK in gambogic acid induced anti‐invasive effect in A549 human lung carcinoma cells , 2015, Molecular carcinogenesis.
[2] Jaana M. Hartikainen,et al. MicroRNA Related Polymorphisms and Breast Cancer Risk , 2014, PloS one.
[3] Liping Peng,et al. Application of ThinPrep Bronchial Brushing Cytology in the Early Diagnosis of Lung Cancer: A Retrospective Study , 2014, PloS one.
[4] P. Conti,et al. Tumor targeting of a cell penetrating peptide by fusing with a pH-sensitive histidine-glutamate co-oligopeptide. , 2014, Biomaterials.
[5] W. Thomas,et al. Affinity Maturation of an ERBB2-Targeted SPECT Imaging Peptide by In Vivo Phage Display , 2014, Molecular Imaging and Biology.
[6] R. Bernards,et al. Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer. , 2014, Cancer discovery.
[7] X. Liu,et al. Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer , 2014, PloS one.
[8] R. Stark,et al. Selection of peptides binding to metallic borides by screening M13 phage display libraries , 2014, BMC Biotechnology.
[9] Tong Zhou,et al. Ion Channel Gene Expression in Lung Adenocarcinoma: Potential Role in Prognosis and Diagnosis , 2014, PloS one.
[10] V. Meininger,et al. Plasma Peptide Biomarker Discovery for Amyotrophic Lateral Sclerosis by MALDI –TOF Mass Spectrometry Profiling , 2013, PloS one.
[11] Jonathan D. Ashley,et al. A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes. , 2013, ACS nano.
[12] Xiangdong Wang,et al. Can lung cancer stem cells be targeted for therapies? , 2012, Cancer treatment reviews.
[13] Kimberly A Kelly,et al. M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer. , 2012, Nature nanotechnology.
[14] Harshal A. Chokhawala,et al. N-Terminal labeling of filamentous phage to create cancer marker imaging agents. , 2012, ACS nano.
[15] E. Choi,et al. Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. , 2012, Biomaterials.
[16] Suresh Senan,et al. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. , 2012, International journal of radiation oncology, biology, physics.
[17] J. Sonke,et al. Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer? , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[18] Su-Jae Lee,et al. Phage Display Screen for Peptides That Bind Bcl-2 Protein , 2011, Journal of biomolecular screening.
[19] B. Strukelj,et al. Peptide Phage Display as a Tool for Drug Discovery: Targeting Membrane Receptors , 2011, Molecules.
[20] A. Jemal,et al. Global Cancer Statistics , 2011 .
[21] Wolfgang A. Weber,et al. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.
[22] D. Boturyn,et al. Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers. , 2007, Anti-cancer agents in medicinal chemistry.
[23] R. Enck,et al. Lung cancer: diagnosis and management. , 2007, American family physician.
[24] T. Daniels,et al. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. , 2006, Clinical immunology.
[25] Miao Wu,et al. In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library. , 2006, Biochemical and biophysical research communications.
[26] Hassan M E Azzazy,et al. Phage display technology: clinical applications and recent innovations. , 2002, Clinical biochemistry.
[27] S. Sidhu,et al. Engineering M13 for phage display. , 2001, Biomolecular engineering.
[28] T. Schumacher,et al. In Vitro Radiolabeling of Peptides and Proteins , 1995, Current protocols in protein science.
[29] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[30] G. P. Smith,et al. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.
[31] I. Bross,et al. The changing histopathology of lung cancer. A review of 1682 cases , 1977, Cancer.